Libreville, Gabon — May 22, 2026 The Gabonese government has presented its pioneering model for conducting Rapid Diagnostic Tests (RDTs) for malaria within pharmacies, a move that has drawn international attention at the 79th World Health Assembly in Geneva. This initiative, which seeks to improve early diagnosis and treatment access across the nation, underscores Gabon’s commitment to tackling malaria, a pressing health concern both domestically and continent-wide.
The model, which has been implemented in schools and pharmacies, is anticipated to significantly diminish the disease’s impact, particularly in underprivileged regions.
The National Medicament and Health Products Agency (ANMAPS) played a crucial role in this initiative, orchestrating a comprehensive training and deployment mission for RDTs across several provinces from January 27 to February 6, 2025. This mission was vital in ensuring healthcare providers, including pharmacists, possessed the necessary skills to utilize the RDTs effectively.
The efficacy of the RDTs has been a focal point, particularly in light of the challenges posed by submicroscopic malaria infections, which are not typically associated with fever.
The RDTs deployed in Gabon are designed to detect these subtle infections, offering a critical tool for early intervention.
The initiative has been positively received by both local and international health experts.
The Gabonese government’s dedication to combating malaria is further evidenced by its collaboration with the World Health Organization (WHO) and other health entities.
The WHO has been actively supporting countries in implementing strategies to combat malaria, including the use of RDTs. While the outlook is optimistic, challenges persist.
The accuracy and reliability of RDTs in detecting submicroscopic infections are areas that necessitate further research and development.
Additionally, ensuring that the tests are accessible and affordable across all regions of Gabon is a crucial factor in the initiative’s success.
The presentation of Gabon’s RDT model at the WHO assembly is a testament to the nation’s progress in public health and a beacon of hope for other African nations addressing similar health challenges.
As the WHO assembly continues, Gabon’s innovative approach to malaria diagnosis and treatment is poised to become a focal point of discussion.
The success of this initiative could have far — reaching implications for malaria control and treatment not only in Gabon but across Africa and beyond.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: Agpgabon
Source: Redaction
